豪鵬科技(001283.SZ):針對智能穿戴類場景的全固態產品已轉入原型設計
格隆匯7月25日丨豪鵬科技(001283.SZ)在互動平臺表示,公司固態電池戰略聚焦消費電子需求痛點——在極致空間內實現高安全、高能量密度、高倍率及長壽命等性能。主要面向AI+端側新興市場需求下的應用場景,此外兼顧如機器人、低空等領域需求。公司已完成高安全性半固態電池的驗證,並已接客戶批量訂單,積極搶佔電源設備安全性升級窗口機遇。與此同時,當前AI+端側設備需求增長迅速,驅動客戶對固態電池的安全、能量密度及形態適配性提出更高要求;目前下遊智能穿戴等品類客戶對固態產品保持高度關注,公司針對智能穿戴類場景的全固態產品已轉入原型設計,並在有序推進與客戶的交流和送樣驗證工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.